Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from PW Medtech Group Ltd. ( (HK:1358) ).
PW Medtech Group Limited reported a 13.9% increase in revenue for the year ended December 31, 2024, driven largely by sales in its Blood Purification Business. Despite a challenging global economic environment and industry reforms in China, the company maintained a stable financial position with a gross profit margin of 54.6%. However, profit attributable to owners decreased by 1.6% year-on-year. The company continues to face challenges due to centralized procurement squeezing profit margins but sees opportunities in innovation and domestic product substitution.
More about PW Medtech Group Ltd.
PW Medtech Group Limited is a leading medical device company in China, focusing on high-margin segments within the medical device industry. The company is committed to expanding into new markets to consolidate its leading position, enhancing its research and development capabilities, and improving its overall competitiveness.
YTD Price Performance: -6.36%
Average Trading Volume: 4,821
Technical Sentiment Signal: Sell
Current Market Cap: €182.4M
For an in-depth examination of 1358 stock, go to TipRanks’ Stock Analysis page.